10 Results for "

Dovitinib

" in MedChemExpress (MCE) Product Catalog:
Products (10)

10 Results for "Dovitinib" in MCE Product Catalog:

11
11 Publications Verification
Cat. No.: HY-50905
CAS No.: 405169-16-6
Synonyms: CHIR-258; TKI258
Target:  

FLT3 c-Kit FGFR VEGFR PDGFR c-Fms

Research Areas:  

Cancer

Dovitinib (CHIR-258) is an orally active, potent multi-targeted tyrosine kinase (RTK) inhibitor with IC50s of 1, 2, 36, 8/9, 10/13/8, 27/210 nM for FLT3, c-Kit, CSF-1R, FGFR1/FGFR3, VEGFR1/VEGFR2/VEGFR3 and PDGFRα/PDGFRβ, respectively. Dovitinib has potent antitumor activity .
loading...
    loading...
11
11 Publications Verification
Cat. No.: HY-10207
CAS No.: 692737-80-7
Purity:  99.75%
Synonyms: CHIR-258 lactate; TKI-258 lactate
Target:  

FLT3 c-Kit FGFR VEGFR PDGFR

Research Areas:  

Cancer

Dovitinib lactate (TKI258 lactate) is a multi-targeted tyrosine kinase inhibitor with IC50s of 1, 2, 8/9, 10/13/8, 27/210 nM for FLT3, c-Kit, FGFR1/3, VEGFR1/2/3 and PDGFRα/β, respectively .
loading...
    loading...
Cat. No.: HY-139682
CAS No.: 2759351-68-1
Purity:  98.93%
Dovitinib RIBOTAC is an RNA-targeting RIBOTAC degrader that can specifically bind to and degrade pre-miR-21. Dovitinib RIBOTAC can inhibit the metastasis of breast cancer and has anti-tumor activity .
loading...
    loading...
Cat. No.: HY-139682A
CAS No.: 2759351-69-2
Purity:  98.97%
Dovitinib RIBOTAC TFA is an RNA-targeting RIBOTAC degrader that can specifically bind to and degrade pre-miR-21. Dovitinib RIBOTAC TFA can inhibit the metastasis of breast cancer and has anti-tumor activity .
loading...
    loading...
Cat. No.: HY-50905R
CAS No.: 405169-16-6
Synonyms: CHIR-258 (Standard); TKI258 (Standard)
Research Areas:  

Cancer

Dovitinib (Standard) is the analytical standard of Dovitinib. This product is intended for research and analytical applications. Dovitinib (CHIR-258) is an orally active, potent multi-targeted tyrosine kinase (RTK) inhibitor with IC50s of 1, 2, 36, 8/9, 10/13/8, 27/210 nM for FLT3, c-Kit, CSF-1R, FGFR1/FGFR3, VEGFR1/VEGFR2/VEGFR3 and PDGFRα/PDGFRβ, respectively. Dovitinib has potent antitumor activity .
loading...
    loading...
Cat. No.: HY-B0062
CAS No.: 915769-50-5
Synonyms: TKI258 lactate hydrate; CHIR-258 lactate hydrate
Target:  

FLT3 c-Kit FGFR VEGFR PDGFR

Research Areas:  

Cancer

Dovitinib lactate hydrate (TKI258 lactate hydrate) is a multi-targeted tyrosine kinase inhibitor with IC50s of 1, 2, 8/9, 10/13/8, 27/210 nM for FLT3, c-Kit, FGFR1/3, VEGFR1/2/3 and PDGFRα/β, respectively .
loading...
    loading...
Cat. No.: HY-139996
CAS No.: 2732969-67-2
Research Areas:  

Cancer

Pomalidomide-C5-Dovitinib is a heterobifunctional PROTAC that recruits KEAP1 E3 ligase to degrade BRD4 and BRD3, but not BRD2 .
loading...
    loading...
Cat. No.: HY-50905S
CAS No.: 1246819-84-0
Dovitinib-d8 is the deuterium labeled Dovitinib. Dovitinib (CHIR-258) is a multi-targeted tyrosine kinase inhibitor with IC50s of 1, 2, 8/9, 10/13/8, 27/210 nM for FLT3, c-Kit, FGFR1/FGFR3, VEGFR1/VEGFR2/VEGFR3 and PDGFRα/PDGFRβ, respectively .
loading...
    loading...
Cat. No.: HY-13892
CAS No.: 852433-84-2
Synonyms: CHIR-258 dilactic acid; TKI258 dilactic acid
Target:  

VEGFR

Research Areas:  

Cancer

Dovitinib (dilactic acid) is an orally active inhibitor of VEGF kinase. Dovitinib (dilactic acid) inhibits receptor tyrosine kinases (RTKs) involved in solid and hematologic cancers and tumor angiogenesis .
loading...
    loading...
Cat. No.: HY-10207R
CAS No.: 692737-80-7
Synonyms: CHIR-258 lactate (Standard); TKI-258 lactate (Standard)
Research Areas:  

Cancer

Dovitinib (lactate) (Standard) is the analytical standard of Dovitinib (lactate). This product is intended for research and analytical applications. Dovitinib lactate (TKI258 lactate) is a multi-targeted tyrosine kinase inhibitor with IC50s of 1, 2, 8/9, 10/13/8, 27/210 nM for FLT3, c-Kit, FGFR1/3, VEGFR1/2/3 and PDGFRα/β, respectively .
loading...
    loading...